In the published article, there was an error in the Funding statement. An incorrect grant number was given for the National Research Foundation grant received by author B-HO. The correct Funding statement appears below.
“This work was supported by the National Research Foundation grant (NRF-2020R1A4A3079755 to B-HO) through the Korean government (MSIP) and CA200422, CA251275, AI140718, AI140705, AI140705-03S1, AI152190, AI171201, DE023926, DE028521, and Korea Research Institute of Bioscience and Biotechnology Research Initiative Program KGM9942012 to JUJ.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
SARS-CoV-2, viral evolution, key epitope, computational affinity maturation, broadly neutralizing antibody, broad-spectrum vaccine
Citation
Jeong B-S, Jeon JY, Lai C-J, Yun H-Y, Jung JU and Oh B-H (2022) Corrigendum: Structural basis for the broad and potent cross-reactivity of an N501Y-centric antibody against sarbecoviruses. Front. Immunol. 13:1103893. doi: 10.3389/fimmu.2022.1103893
Received
21 November 2022
Accepted
22 November 2022
Published
08 December 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
13 - 2022
Updates
Copyright
© 2022 Jeong, Jeon, Lai, Yun, Jung and Oh.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Byung-Ha Oh, bhoh@kaist.ac.kr; Jae U. Jung, jungj@ccf.org
This article was submitted to Vaccines and Molecular Therapeutics, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.